Section of Endocrine Surgery, UCLA David Geffen School of Medicine, 10833 Le Conte Avenue, 72-182 CHS, Los Angeles, CA 90095, USA.
Section of Endocrine Surgery, UCLA David Geffen School of Medicine, 10833 Le Conte Avenue, 72-250 CHS, Los Angeles, CA 90095, USA.
Endocrinol Metab Clin North Am. 2017 Mar;46(1):87-104. doi: 10.1016/j.ecl.2016.09.012. Epub 2016 Dec 14.
Primary hyperparathyroidism (PHPT) is the most common cause of chronic hypercalcemia. With the advent of routine calcium screening, the classic presentation of renal and osseous symptoms has been largely replaced with mild, asymptomatic disease. In hypercalcemia caused by PHPT, serum parathyroid hormone levels are either high, or inappropriately normal. A single-gland adenoma is responsible for 80% of PHPT cases. Less frequent causes include 4-gland hyperplasia and parathyroid carcinoma. Diminished bone mineral density and nephrolithiasis are the major current clinical sequelae. Parathyroidectomy is the only definitive treatment for PHPT, and in experienced hands, cure rates approach 98%.
原发性甲状旁腺功能亢进症(PHPT)是慢性高钙血症最常见的原因。随着常规钙筛查的出现,肾脏和骨骼症状的典型表现已在很大程度上被轻度、无症状的疾病所取代。在由 PHPT 引起的高钙血症中,甲状旁腺激素水平要么升高,要么不适当的正常。单腺腺瘤占 PHPT 病例的 80%。不太常见的原因包括 4 腺增生和甲状旁腺癌。骨密度降低和肾结石是目前主要的临床后遗症。甲状旁腺切除术是 PHPT 的唯一确定性治疗方法,在有经验的医生手中,治愈率接近 98%。